Lipoxygenase inhibitors are used as cytoprotective active ingredient in producing cytoprotective pharmaceutical compositions. Corresponding cytoprotective pharmaceutical compositions are prepared by incorporating into a pharmaceutical composition a lipoxygenase inhibitor in a cytoprotective active amount. The prepared cytoprotective therapeutic composition may be used to treat or prevent disease states such as erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol. The lipoxygenase inhibitors induce cytoprotection via an unspecified mechanism.
脂
氧合酶
抑制剂作为细胞保护活性成分可用于生产细胞保护药物组合物。相应的细胞保护药物组合物是通过在药物组合物中加入具有细胞保护活性量的脂
氧合酶
抑制剂来制备的。制备的细胞保护治疗组合物可用于治疗或预防疾病状态,如糜烂性胃炎、糜烂性食管炎、炎症性肠病和诱导性出血性胃糜烂,如由
吲哚美辛或
乙醇引起的胃糜烂。脂
氧合酶
抑制剂通过不明机制诱导细胞保护。